Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Outlook Therapeutics Inc (OTLKW)
Outlook Therapeutics Inc (OTLKW) Financials

OTLKW Outlook Therapeutics Inc

0.03

0.00 (0.00%)

18 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 30 September 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-215.161	-180.135	-223.256	-182.861	-265.13	-249.92	-257.317	-193.931
Return on Equity (%)	210.294	206.049	162.237	172.962	734.782	-1430.459	-989.988	2069.216
Return on Invested Capital (%)	190.207	294.989	133.657	167.433	1238.293	-610.626	-566.506	1340.226
Operating Margin (%)	-1736.846	-858.395	-966.613	-423.128	N/A	N/A	N/A	N/A
Net Profit Margin (%)	-2119.664	-1050	-1555.019	-442.426	N/A	N/A	N/A	N/A
Book Value Per Share	-0.228	-1.35	-0.288	-0.376	0.022	0.026	0.038	-0.055
Earnings Per Share	-2.77	-1.605	-0.665	-1.26	-0.384	-0.301	-0.291	-0.227
Cash Per Share	0.103	0.128	0.024	0.28	0.099	0.082	0.077	0.09
Working Capital Per Share	-0.647	-0.996	-0.398	-0.237	0.016	0.084	0.034	-0.061
Operating Profit Per Share	0.131	0.153	0.043	0.285	N/A	N/A	N/A	N/A
EBIT Per Share	-2.334	-1.538	-0.467	-1.326	-0.303	-0.301	-0.291	-0.227
EBITDA Per Share	-2.334	-1.538	-0.467	-1.326	-0.303	-0.301	-0.291	-0.227
Free Cash Flow Per Share	-2.827	-1.702	-0.669	-1.362	-0.386	-0.302	-0.291	-0.227

Liquidity Ratios

Year End 30 September 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	22.8M	24.93M	72.22M	28.61M	127.18M	176.46M	227.31M	N/A

Key Stats and Ratios

Year End 30 September 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	227.31M	256.67M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	7.81M
Price to Earnings Ratio	-22.73
Price to Sales Ratio	0
Price to Cash Ratio	57.29
Price to Book Ratio	-92.83
Dividend Yield	-

Share Statistics

Shares Outstanding	260.25M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Outlook Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions